ANI Completes Alimera Merger After Legal Back And Forth
The Deal Adds Two Commercialized Drugs Into ANI’s Portfolio
After being sued by Alimera earlier this month, ANI has now completed its acquisition of the company, boosting its commercialized drug portfolio with two original products.
